Physician profile
Dale E Rutledge
NPI 1770529760
$6,962.24
in general payments reported to CMS, 2019-2025
14 companies · $93.59 in 2025
The $93.59 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.81 · 2020: $27.79 · 2021: $6,348 · 2022: $237 · 2023: $142 · 2024: $65.82 · 2025: $93.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.81 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,296.90 | 2021 | |
| Abbvie INC. | $147.48 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.24 | 2019-2025 | |
| Astellas Pharma US INC | $72.99 | 2023 | |
| Pfizer INC. | $63.01 | 2019-2024 | |
| Organon LLC | $62.33 | 2022-2025 | Nexplanon |
| Kowa Pharmaceuticals America, INC. | $58.75 | 2022-2023 | Seglentis |
| Biogen, INC. | $47.45 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $37.89 | 2021-2022 | |
| Therapeuticsmd, INC. | $25.85 | 2019-2022 | |
| Hologic Sales and Service, LLC | $17.12 | 2023 | Aptima |
| Sanofi Pasteur INC. | $15.27 | 2024 | |
| Merck Sharp & Dohme LLC | $13.75 | 2020 | |
| Exeltis, USA INC. | $13.21 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Rutledge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.